IDC recognizes Wipro for R&D, ITO & BPO

As per the latest update, Wipro  has been named a
“Leader” in both R&D ITO & BPO by advisory and research firm International Data Corporation (IDC) in its report IDC MarketScape: Worldwide Life Science Research & Development – BPO 2013 Vendor Assessment, Doc #244934, December 2013 and IDC MarketScape: Worldwide Life Science Research & Development – ITO  2013 Vendor Assessment, Doc #HI245309, December 2013.
 
After a close evaluation of Wipro's offerings and capabilities, IDC MarketScape has positioned Wipro in the “Leaders” category within R&D ITO and R&D BPO. Relative to other vendors discussed in these reports, and based on the feedback from multiple customer references, Wipro received high marks for its strong technical team, solid account relationships, and ability to deliver high value for money.
 
Manoj Punja, Senior Vice-President & Global Head, Wipro BPO, said, “The Life Sciences industry is a huge focus area for Wipro BPO and we are investing significantly in this space. To be named as a Leader by IDC is, indeed, a validation of our investments and strategy in building differentiated industry capabilities, regulatory knowledge, analytics  and best-of-class operations for this market.’’
 
Within the Life Science R&D BPO space, Wipro has been quoted as a strong player, particularly in the area of delivering enterprise content document management, drug safety services, post market surveillance, and training services. In the Life Science R&D ITO space, Wipro is particularly strong in delivering both industry-specific and industry-agnostic engineering and software ITO services, supplemented by a broad portfolio of traditional life science ITO offerings.